Cytek Biosciences, Inc.

Founded in 1992 and headquartered in Fremont, California, Cytek Biosciences manufactures cell analysis instruments and reagents for biomedical research and clinical applications. The company's core product portfolio includes the Aurora and Northern Lights systems, which utilize full spectrum profiling technology for cell analysis and sorting, along with the Amnis ImageStream imaging flow cytometers. Additional offerings include Guava Muse and EasyCyte flow cytometers, Orion reagent cocktail preparation systems, and associated software platforms such as SpectroFlo. The company also manufactures cFluor reagents—fluorochrome conjugated antibodies used to identify cells of interest—and provides automated sample handling equipment designed to integrate with its primary instrument systems.

Cytek serves pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes products through a direct sales force and support infrastructure across North America, Europe, China, and the Asia-Pacific region, supplemented by distributors and sales agents in Europe, Latin America, and the Middle East. The company operates at a market capitalization of approximately $0.6 billion and generates revenue from both instrument sales and consumable reagent kits, which provide recurring revenue streams from existing customer bases.